Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H2AZ2 pseudogene 1 (H2AZ2P1) is classified as a pseudogene related to the histone H2A.Z variant family, particularly H2A.Z.2. Unlike the protein-coding H2AZ2 gene, which encodes the H2A.Z.2 histone variant involved in chromatin structure, gene regulation, and is implicated in several cancers and developmental syndromes[5][1][2], H2AZ2P1 does not code for a functional protein. No therapeutic relevance, biological function, or disease association is currently attributed to this pseudogene. Entries referencing H2AZ2P1 are likely to be errors if used in the context of drug discovery or molecular pharmacology and should be corrected to refer to the functional H2AZ2 (H2A.Z.2) gene instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H2A.Z variant histone 2 pseudogene 1 (H2AZ2P1).